行情

MTP

MTP

Midatech Pharma
NASDAQ

实时行情|Nasdaq Last Sale

1.760
-0.080
-4.35%
已收盘, 18:13 09/20 EDT
开盘
1.790
昨收
1.840
最高
1.844
最低
1.760
成交量
4.63万
成交额
--
52周最高
3.830
52周最低
1.600
市值
3,466.09万
市盈率(TTM)
-0.4971
分时
5日
1月
3月
1年
5年
Midatech Pharma PLC 公布中期业绩通知
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it will release its interim resul...
ACCESSWIRE · 09/06 06:00
Midatech Pharma PLC 宣布任命首席科学官
Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific OfficerABINGDON, OXFORDSHIRE / ACCESSWIRE / July 12, 2021 / Midatech Pharma PLC (AIM:MTPH; Nasdaq:MTP), a ...
ACCESSWIRE · 07/12 13:50
Midatech Pharma 获得 1000 万英镑的股权以资助产品开发
Benzinga · 06/29 13:01
Midatech Pharma 宣布在英国发售 3500 万股,定价为 0.285 英镑/配售股
Midatech Pharma PLC (Nasdaq: MTP) announces that it has raised £10.0 million (before expenses) by way of a placing to investors in the UK ("Placing") of 35,087,720 new ordinary shares of 0.1p each ("Placing Shares") at an issue price of £0.285 per Placing ...
Benzinga · 06/29 09:29
从昨天开始的 48 个最大的推动者
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.
Benzinga · 06/22 09:13
12只医疗保健股在周一盘中交易
 
Benzinga · 06/21 16:39
从昨天开始的 50 个最大的推动者
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share.
Benzinga · 06/18 09:03
网络研讨会重点介绍 Q-Sphera 平台,Midatech 创四个月新高
sefa ozel/E+ via Getty Images The nano-cap biotech company, Midatech Pharma ([[MTP]] +35.8%) looks set to record its biggest one-day gain in more than four months and reach the highest
Seekingalpha · 06/17 17:14
更多
财务预测
暂无数据
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解MTP最新的财务预测,通过MTP每股收益,每股净资产,每股现金流等数据分析Midatech Pharma近期的经营情况,然后做出明智的投资选择。
暂无数据
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-2.58%
制药与医学研究
-1.08%
高管信息
Non-Executive Chairman
Rolf Stahel
Chief Executive Officer/Chief Financial Officer/Director
Stephen Stamp
Chief Scientific Officer
Dmitry Zamoryakhin
Other
Justin Barry
Other
Tim Sparey
Non-Executive Director
Simon De Vries
Non-Executive Independent Director
Simon Turton
暂无数据
MTP 简况
Midatech Pharma PLC是一家研发生物制药公司,专注于肿瘤学和其他治疗领域产品的商业化和开发。该公司运营产品线研发部门。产品线研发部门利用纳米医学和缓释技术平台开发产品。该公司采用其药物输送技术开发化学疗法或新型免疫疗法。Q-Sphera平台是一种用于持续微释放的聚合物微球技术,可在数周至数月的延长时间内延长并控制治疗剂的释放。Midasolve平台是其纳米糖技术,可用于纳米级溶解药物,以便直接以液体形式和局部给药到肿瘤中。Midacore平台是一种金纳米颗粒技术,用于纳米级靶向疾病部位。

微牛提供Midatech Pharma PLC-ADR(NASDAQ-MTP)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的MTP股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MTP股票基本功能。